Tracking COVID-19 symptoms through the American Cancer Society’s Cancer Prevention Study-3 (CPS-3)
How will COVID-19 impact cancer risk and survivorship? The American Cancer Society is inviting participants in its ongoing Cancer Prevention Study-3 (CPS-3) to use a new app to help investigators track the COVID-19 epidemic and inform future research efforts. Dr. Alpa Patel explains that understanding how COVID-19 infection is affecting patients—in combination with all the other data that she and her team are collecting through CPS-3 on an ongoing basis—will help answer some very important questions about the impact of COVID-19 on cancer risk and survivorship. Alpa Patel, PhD, is Sr. Scientific Director of Epidemiology Research and the Principal Investigator of Cancer Prevention Study-3 at the American Cancer Society. The app, the COVID Symptom Tracker (https://covid.joinzoe.com/us), was created by doctors and scientists at the Harvard T.H. Chan School of Public Health, Massachusetts General Hospital, King's College London, and Stanford University School of Medicine, working in partnership with the health science company ZOE. Participants simply download the app and each day, track whether they are feeling any symptoms. 3:05 – On the American Cancer Society’s Cancer Prevention Study-3, or CPS-3 4:38 – How CPS-3 participants stay involved during the life of the study 6:06 – What makes CPS-3 such a valuable resource? 8:00 – How and when results from CPS-3 are shared with the scientific and cancer community 9:48 – On what CPS-3 can tell us about physical activity and cancer risk 13:05 – On the addition of the COVID-19 Symptom Tracker app to CPS-3 15:40 – How information from the app in combination of data from CPS-3 could be used to help cancer patients 18:31 – Some of the exciting ways that data from the app could be integrated from information collected through CPS-3, and how that could help cancer patients 21:58 – When data from the COVID-19 Symptom Tracker app might be ready to share 23:01 – What she’s most excited about in terms of the potential impact of CPS-3 25:21 – A message she’d like to share with cancer patients and caregivers